Cargando…

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae

Detalles Bibliográficos
Autores principales:	Chea, Nora, Bulens, Sandra N., Kongphet-Tran, Thiphasone, Albrecht, Valerie, Lynfield, Ruth, Shaw, Kristin M, Kainer, Marion, Muleta, Daniel, Wilson, Lucy, Vaeth, Elisabeth, Dumyati, Ghinwa, Concannon, Cathleen, Phipps, Erin C., Culbreath, Karissa, Janelle, Sarah Jackson, Bamberg, Wendy, Kallen, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781458/ http://dx.doi.org/10.1093/ofid/ofu051.172

Ejemplares similares

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

1640 Antibiotic Use Patterns in a Population with Long Term Care-Onset C. difficile Infection Developing after Recent Hospitalization
por: Felsen, Christina, et al.
Publicado: (2014)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
por: Walters, Maroya Spalding, et al.
Publicado: (2019)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

347 Antimicrobial Susceptibility of OXA-48, NDM-1 And VIM-4 Carbapenemase-producing Clinical Isolates of Enterobacteriaceae From Kuwait Government Hospitals
por: Jamal, Wafaa, et al.
Publicado: (2014)

Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera — United States, 2014–2017
por: Walters, Maroya S., et al.
Publicado: (2018)

363 Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013
por: Adler, Amos, et al.
Publicado: (2014)

“It’s like fighting a war with rocks”: Nursing home healthcare workers’ experiences during the COVID-19 pandemic
por: Seshadri, Sandhya, et al.
Publicado: (2020)

142 Retrospective, multicenter, point prevalence study of urinary tract infection (UTI) data for a city-wide antimicrobial stewardship initiative
por: Hoffmann, Chas, et al.
Publicado: (2014)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018
por: Grass, Julian E, et al.
Publicado: (2019)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020
por: Duffy, Nadezhda, et al.
Publicado: (2023)

1641 Evaluation of Co-Infections among Patients with Community-Associated Clostridium difficile Infection
por: Cohen, Jessica, et al.
Publicado: (2014)

Global Spread of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2011)

Carbapenemase-producing Enterobacteriaceae, U.S. Rivers
por: Aubron, Cécile, et al.
Publicado: (2005)

Rapid Detection of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2012)

Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy
por: Cui, Xiaoyan, et al.
Publicado: (2019)

360 Surveillance for Carbapenemase-Producing Bacteria in the Wake of a Nosocomial Outbreak
por: Odom, Robin T., et al.
Publicado: (2014)

333 Detection of Carbapenemase-Producing Aeromonas hydrophila on Perirectal Surveillance Culture
por: Hughes, Heather Y., et al.
Publicado: (2014)

524 National estimates of incidence, recurrence, hospitalization, and death of nursing home-onset Clostridium difficile infections — United States, 2012
por: Hunter, Jennifer C., et al.
Publicado: (2014)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae and Duodenoscopes in the Department of Veterans Affairs
por: Ryono, Russell, et al.
Publicado: (2015)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013
por: Johnson, Brian, et al.
Publicado: (2014)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

364 Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization
por: Lewis, Jessica, et al.
Publicado: (2014)

Detection of carbapenemase production in Enterobacteriaceae and Pseudomonas species by carbapenemase Nordmann–Poirel test
por: Rao, Morubagal R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pkbfi7v3abtt8f4megt27821vf